RETATRUTIDE – 20MG

What Is Retatrutide (LY3437943)

Retatrutide, developed under the code LY3437943, is a once-weekly peptide engineered to engage three incretin-family receptors at once. The GLP-1 and GIP components reduce energy intake, while the glucagon component raises energy expenditure — a combination that single and dual agonists cannot replicate.